Expression of human complement receptor 2 (CR2, CD21) in Cr2(-/-) mice restores humoral immune function

Journal of Immunology

Volumn 165, Issue 5, 2000, Pages 2354-2361

  Marchbank, K J ^a   Watson, C C ^a   Ritsema, D F ^a   Holers, V M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

EID: 0034283957     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.5.2354     Document Type: Article

References (41)

1. The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity
2. Complement and the immune response
3. The CDI9/CD21 signal transduction complex of B lymphocytes
4. The regulators of complement activation (RCA) gene cluster
5. Structure and function of complement receptors, CRI (CD35) and CR2 (CD21)
6. A molecular and immunological characterization of mouse CR2: Evidence for a single gene model of mouse complement receptors I and 2
7. The murine complement receptor gene family IV: Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CRI
8. Comparative structure and evolution of murine CR2: The homolog of the human C3d/EBV receptor (CD21)
9. Analysis of C3b/C3d binding sites and the factor I cofactor regions within mouse complement receptors 1 and 2
10. Expression of C3d receptors during B cell differentiation: Immunofluorescence analysis with the HB-5 monoclonal antibody
11. Monoclonal antibodies to mouse complement receptor type I (CRI): Their use in a distribution study showing that mouse erythrocytes and platelets are CRl-negative
12. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor
13. Human follicular dendritic cells express CRI, CR2, and CR3 complement receptor antigens
14. Expression of complement receptors CRI and CR2 on murine follicular dendritic cells and B lymphocytes
15. Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies
16. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes
17. Epstein-Barr vires receptors on human pharyngeal epithelia
18. CD21 is a ligand for CD23 and regulates IgE production
19. Epstein-Barr vires gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis
20. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein Barr vires (EBV) to the EBV/C3d receptor of B cells: Sequence homology of gp350 and C3 complement fragment C3d
21. Analysis of Epstein-Barr vires-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides
22. Role of complement in induction of antibody production in vivo: Effect of cobra venom factor and other C3 reactive reagents on thymusdependant and thymus-independent antibody response
23. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
24. Intersection of the complement and immune systems: A signal transduction complex on human B lymphocytes containing complement receptor type 2 and CD19
25. CD19 expression levels regulate B lymphocyte development
26. The CD19/CD21 sigfial transducing complex of human B lymphocytes includes the target of anti-proliferation antibody-1 and leu-13 molecules
27. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD8l-deficient mice
28. Normal lymphocyte development but delayed humoral immune response in CD81-null mice
29. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
30. Disruption of the Cr2 locus results in a reduction in B-la cells and in an impaired B cell response to T-dependant antigen
31. Expression of complement receptors I and 2 on follicular dendritic cells is necessary for the generation of a normal antigen-specific IgG response
32. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene
33. Genomic organization and polymorphisms of the human C3d/Epstein-Barr vires receptor
34. The murine complement receptor gene family. III. The genomic and transcriptional complexity of the Crry and Crry-ps genes
35. Mouse Crry/p65: Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF
36. An enzyme-linked immunosorbent assay for measuring anti-sheep erythrocyte antibodies
37. The signaling activity of murine CD19 is regulated during B cell development
38. Molecular interactions of complement receptors on B lymphocytes: A CR1/CR2 complex distinct from the CR2/CD19 complex
39. Immunoglobulin production by peripheral lymphocytes induced by anti-C3 receptor antibodies
40. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation
41. Epstein-Barr vires uses HLA class II as a cofactor for infection of B lymphocytes